Phase 1b ATMOS trial of the inhaled sGC activator mosliciguat in patients with PAH/CTEPH.

Ghofrani HA, Leuchte HH, Al-Hiti H, Halank M, Jansa P, Lange T, Olschewski H, Tello K, Becker-Pelster E, Ligges S, Nagelschmitz J, Nikkho S, Penugonda S, Saleh S, Vesterinen P, Woischnik M, Jung D, Kopec G

Open source

DOI: 10.1136/thorax-2025-224583
Published: 2026 Sep 11
Container: Thorax
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/thorax-2025-224583,
  title = {Phase 1b ATMOS trial of the inhaled sGC activator mosliciguat in patients with PAH/CTEPH.},
  author = {Ghofrani HA and Leuchte HH and Al-Hiti H and Halank M and Jansa P and Lange T and Olschewski H and Tello K and Becker-Pelster E and Ligges S and Nagelschmitz J and Nikkho S and Penugonda S and Saleh S and Vesterinen P and Woischnik M and Jung D and Kopec G},
  year = {2026},
  journal = {Thorax},
  doi = {10.1136/thorax-2025-224583},
  url = {https://doi.org/10.1136/thorax-2025-224583}
}

RIS

TY  - JOUR
TI  - Phase 1b ATMOS trial of the inhaled sGC activator mosliciguat in patients with PAH/CTEPH.
AU  - Ghofrani HA
AU  - Leuchte HH
AU  - Al-Hiti H
AU  - Halank M
AU  - Jansa P
AU  - Lange T
AU  - Olschewski H
AU  - Tello K
AU  - Becker-Pelster E
AU  - Ligges S
AU  - Nagelschmitz J
AU  - Nikkho S
AU  - Penugonda S
AU  - Saleh S
AU  - Vesterinen P
AU  - Woischnik M
AU  - Jung D
AU  - Kopec G
PY  - 2026
JO  - Thorax
DO  - 10.1136/thorax-2025-224583
UR  - https://doi.org/10.1136/thorax-2025-224583
ER  -

APA

HA, G., HH, L., H, A., M, H., P, J., T, L., H, O., K, T., E, B., S, L., J, N., S, N., S, P., S, S., P, V., M, W., D, J., & G, K. (2026). Phase 1b ATMOS trial of the inhaled sGC activator mosliciguat in patients with PAH/CTEPH.. Thorax. https://doi.org/10.1136/thorax-2025-224583

Source records

pubmed · retrieved 2026-09-25T16:51:49.605Z